A tumor heterogeneity-independent antigen-responsive nanocarrier enabled by bioorthogonal pre-targeting and click-activated self-immolative polymer.

Bioorthogonal pre-targeting alleviate the limitations of traditional nanomedicines in passive and active targeting delivery. However, the high selectivity of bioorthogonal pre-targeting depends on the high expression level of antigens in lesion sites, and there are very limited targets with sufficient overexpression. Herein, we propose a tumor heterogeneity-independent antigen-responsive nanocarrier utilizing bioorthogonal pre-targeting and click-activated self-immolative polymers for stimulus signal conversion and amplification.

A Wireless Operated Flexible Bioelectronic Microneedle Patch for Actively Controlled Transdermal Drug Delivery.

Precise control over drug release rates is critical for enhancing therapeutic efficacy, reducing side effects, and maintaining stable drug levels. While microneedles (MNs) offer a promising approach for transdermal drug delivery, conventional passive-response systems often lack adaptability across diverse drugs and disease models, limiting their versatility. Here, this work presents a flexible bioelectronic microneedle patch (FBMP) that integrates flexible electronics for actively controlled transdermal delivery.